When an investigator or company contact you to discuss taking part in any clinical study please remember that your safety is paramount and you should ensure that you are aware of all the information about the study before taking part and that you ask questions of the doctors and medical professionals involved. The Clinical Trials industry is heavily regulated and the standards of care that you will receive from reputable organizations will be very high. They are trained and willing to answer any questions that you have.
Because your safety is their primary concern, you should stay under their care throughout the study which may sometimes include overnight stays.
Read our Terms and Conditions.
For some more FAQs please read our Frequenty Asked Questions.
Study likely spells end for anti-bleeding drug:
“In all likelihood, this is the end of the aprotinin story”
Bayer AG, the maker of the drug Trasylol, said it is still deciding what to do and is awaiting details from the Canadian study. …
Novel Treatment Offers Insomnia Sufferers Hope Of Quality Sleep: A new, first in class sleep medication is launched, offering hope for thousands of sufferers of insomnia in Europe. Circadin(R), sustained-release melatonin, provides natural sleep by increasing the…
Adding Breast Ultrasound Screening To Mammography Reveals Cancers Not Seen On Mammography Alone In Women At Increased Risk For Breast Cancer: In women at increased risk for breast cancer, adding a screening ultrasound examination to routine mammography revealed 28 percent more cancers than mammography alone. However, the additional…
NicOx Announces Initiation Of First Phase 1 Study Of Investigational Nitric Oxide-Donating Agent In Hypertensive Patients By Merck & Co., Inc.: NicOx S.A. (Eurolist: COX) announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies’…
AviaraDx Confirms That Combination Of Two Molecular Biomarkers Improves Prediction Of Disease Recurrence In Early Stage Breast Cancer Patients: AviaraDx, Inc. announced the publication of an article describing the discovery, development and validation of a new molecular biomarker, Aviara MGI(SM) (Molecular Grade Index), that improves the…
